GLP1R and diabetes mellitus: Post‐hoc mediation analysis from the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial showed that between 41% and 83% of the total preventive effect of GLP‐1 RA was mediated by the HbA1c reduction.24